Participants 61 98 4
acute myelogenous leukemia in relapse
Participants 130 331 5
Patients with acute myelogenous leukemia in relapse who were ineligible for further anthracycline therapy either because they were judged to be anthracycline resistant or had received the maximum doses
Participants 505 613 5
three of 25 patients given high-dose cytarabine and three of 23 given amsacrine obtained complete remissions
